Blog

- October 27, 2026

3D-printed implant prototype combines brain activity recording with targeted cooling

Researchers affiliated with the Leibniz Institute of Polymer Research Dresden (IPF) and the Else Kröner Fresenius Center (EKFZ) for Digital Health at TU Dresden have developed a 3D-printed implant prototype that combines the recording of brain activity with targeted cooling. The technology could pave the way for alternative approaches to treating drug-resistant focal epilepsy. The research is published in the journal Advanced Science.

Read More »

Vincora Receives FDA Approval to Initiate U.S. Early Feasibility Study of Transcatheter Chordal Repair System

MAPLE GROVE, Minn., Oct. 27, 2026 /PRNewswire/ — Vincora (NeoChord, Inc. d/b/a Vincora), a medical technology company developing transcatheter therapies for mitral valve repair, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational Device Exemption (IDE) to initiate a U.S. Early Feasibility Study (EFS) of its investigational Transcatheter Chordal Repair System for the treatment of degenerative mitral valve regurgitation.

Read More »